BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 17653732)

  • 1. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
    Nakashima-Yasuda H; Uryu K; Robinson J; Xie SX; Hurtig H; Duda JE; Arnold SE; Siderowf A; Grossman M; Leverenz JB; Woltjer R; Lopez OL; Hamilton R; Tsuang DW; Galasko D; Masliah E; Kaye J; Clark CM; Montine TJ; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2007 Sep; 114(3):221-9. PubMed ID: 17653732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.
    Kokoulina P; Rohn TT
    Neurodegener Dis; 2010; 7(4):243-50. PubMed ID: 20551689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
    Arai T; Mackenzie IR; Hasegawa M; Nonoka T; Niizato K; Tsuchiya K; Iritani S; Onaya M; Akiyama H
    Acta Neuropathol; 2009 Feb; 117(2):125-36. PubMed ID: 19139911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neuropathological correlates of Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Sobue G
    Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
    Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
    Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.
    McAleese KE; Walker L; Erskine D; Thomas AJ; McKeith IG; Attems J
    Brain Pathol; 2017 Jul; 27(4):472-479. PubMed ID: 27495267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
    Hishikawa N; Niwa J; Doyu M; Ito T; Ishigaki S; Hashizume Y; Sobue G
    Am J Pathol; 2003 Aug; 163(2):609-19. PubMed ID: 12875980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
    Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
    Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
    Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
    Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.
    Uchihara T
    Neuropathology; 2017 Apr; 37(2):129-149. PubMed ID: 27862327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
    Amador-Ortiz C; Lin WL; Ahmed Z; Personett D; Davies P; Duara R; Graff-Radford NR; Hutton ML; Dickson DW
    Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.